U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259447) titled 'Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer' on Nov. 14.
Brief Summary: Locally advanced non-small cell lung cancer (LA-NSCLC) patients could benefit in overall and progression-free survival from regular dosimetric treatment plan adaptations during radiotherapy. This is known as adaptive radiotherapy (ART). However, implementing an adaptive radiotherapy workflow presents a highly cumbersome process. First, repeated planning-CT imaging during treatment is required, which results in additional radiation dose for patients. Second, an ART workflow includes the repetition of various manual and semi-automated ...